Ipilimumab/nivolumabBullous pemphigoid: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1769卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67274-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：260 / 260

相关论文

共 50 条

[31] NivolumabBullous pemphigoid and erythema multiforme: 3 case reports
Reactions Weekly, 2017, 1662 (1) : 276 - 276
[32] NivolumabBullous lichen planus: case report
Reactions Weekly, 2020, 1796 (1) : 185 - 185
[33] NivolumabBullous lichenoid drug eruption: case report
Reactions Weekly, 2019, 1748 (1) : 378 - 378
[34] Ipilimumab/Nivolumab/PembrolizumabBullous pemphigoid: 7 case reports
Reactions Weekly, 2025, 2050 (1) : 286 - 286
[35] Ipilimumab/methotrexate/pembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1617 (1) : 143 - 143
[36] Ipilimumab/pembrolizumabBullous pemphigoid and dermatitis herpetiformis: 2 case reports
Reactions Weekly, 2017, 1673 (1) : 216 - 216
[37] RosuvastatinFirst report of pemphigoid: case report
Reactions Weekly, 2012, 1418 (1) : 39 - 39
[38] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[39] Ipilimumab/pembrolizumabIleus: case report
Reactions Weekly, 2023, 1956 (1) : 287 - 287
[40] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2021, 1854 (1) : 199 - 199

← 1 2 3 4 5 →